Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quentin M Anstee

Showing results (51-60 of 261) with videos related to

Pageof 27
Sort By:
Expert Review of Gastroenterology & Hepatology|September 8, 2021
Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature reviewJörn M Schattenberg, Quentin M Anstee, Cyrielle Caussy, et al.
Hepatology (Baltimore, Md.)|December 16, 2014
TM6SF2 as a genetic risk factor for fibrosisAnn K Daly, Christopher P Day, Yang-Lin Liu, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?Stuart McPherson, Quentin M Anstee, Elsbeth Henderson, et al.
Journal of Medical Internet Research|January 15, 2021
Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention MappingKate Hallsworth, Stuart McPherson, Quentin M Anstee, et al.
BMJ Open|January 5, 2022
Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesisHelen Jarvis, Hannah O'Keefe, Dawn Craig, et al.
Journal of Hepatology|January 22, 2014
Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Elsbeth Henderson, Alastair D Burt, et al.
Hepatology (Baltimore, Md.)|May 1, 2010
Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver?Adam P Levene, Hiromi Kudo, Mark R Thursz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2017
Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical PracticeLeah Avery, Catherine Exley, Stuart McPherson, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2024
Letter: Beyond advanced fibrosis-The critical need for assessing NITs performance in identifying F2-F3 fibrosis. Authors' replyStuart McPherson, Jessica K Dyson, Laura Jopson, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2024
Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' replyStuart McPherson, Jessica K Dyson, Laura Jopson, et al.
Pageof 27

Showing results (51-60 of 261) with videos related to

Sort By:
Pageof 27
Expert Review of Gastroenterology & Hepatology|September 8, 2021
Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature reviewJörn M Schattenberg, Quentin M Anstee, Cyrielle Caussy, et al.
Hepatology (Baltimore, Md.)|December 16, 2014
TM6SF2 as a genetic risk factor for fibrosisAnn K Daly, Christopher P Day, Yang-Lin Liu, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?Stuart McPherson, Quentin M Anstee, Elsbeth Henderson, et al.
Journal of Medical Internet Research|January 15, 2021
Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention MappingKate Hallsworth, Stuart McPherson, Quentin M Anstee, et al.
BMJ Open|January 5, 2022
Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesisHelen Jarvis, Hannah O'Keefe, Dawn Craig, et al.
Journal of Hepatology|January 22, 2014
Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Elsbeth Henderson, Alastair D Burt, et al.
Hepatology (Baltimore, Md.)|May 1, 2010
Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver?Adam P Levene, Hiromi Kudo, Mark R Thursz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2017
Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical PracticeLeah Avery, Catherine Exley, Stuart McPherson, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2024
Letter: Beyond advanced fibrosis-The critical need for assessing NITs performance in identifying F2-F3 fibrosis. Authors' replyStuart McPherson, Jessica K Dyson, Laura Jopson, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2024
Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' replyStuart McPherson, Jessica K Dyson, Laura Jopson, et al.
Pageof 27